180 related articles for article (PubMed ID: 2292531)
1. Epidemiological features and chemotherapy of community-acquired respiratory tract infections.
Finch RG
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():53-61. PubMed ID: 2292531
[TBL] [Abstract][Full Text] [Related]
2. Optimizing antibacterial therapy for community-acquired respiratory tract infections in children in an era of bacterial resistance.
Low DE; Pichichero ME; Schaad UB
Clin Pediatr (Phila); 2004 Mar; 43(2):135-51. PubMed ID: 15024437
[TBL] [Abstract][Full Text] [Related]
3. Update on pneumococcal infections of the respiratory tract.
Tan TQ
Semin Respir Infect; 2002 Mar; 17(1):3-9. PubMed ID: 11891513
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of upper respiratory tract infections in the primary care setting.
Fendrick AM; Saint S; Brook I; Jacobs MR; Pelton S; Sethi S
Clin Ther; 2001 Oct; 23(10):1683-706. PubMed ID: 11726004
[TBL] [Abstract][Full Text] [Related]
5. Bacterial infections of the upper respiratory airways and beta-lactam antibiotics.
Lundberg C
Scand J Infect Dis Suppl; 1984; 42():122-8. PubMed ID: 6597557
[TBL] [Abstract][Full Text] [Related]
6. Use of antimicrobial agents for upper respiratory tract infections in Taiwanese children.
Huang YH; Huang YC
Chang Gung Med J; 2005 Nov; 28(11):758-64. PubMed ID: 16422181
[TBL] [Abstract][Full Text] [Related]
7. Upper respiratory tract infections in family practice.
Ruoff G
Pediatr Infect Dis J; 1998 Aug; 17(8 Suppl):S73-8. PubMed ID: 9727654
[TBL] [Abstract][Full Text] [Related]
8. Clinical aspects on antibiotic resistance: upper respiratory tract infections.
Prellner K
Microb Drug Resist; 1995; 1(2):143-7. PubMed ID: 9158748
[TBL] [Abstract][Full Text] [Related]
9. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
[TBL] [Abstract][Full Text] [Related]
10. [Rational antibiotic therapy of acute upper respiratory tract infections].
Mazur E
Pol Merkur Lekarski; 2010 Nov; 29(173):304-8. PubMed ID: 21268914
[TBL] [Abstract][Full Text] [Related]
11. Guidelines to rational use of antibiotics in acute upper respiratory tract infections in Chinese children.
Yang Y; Lu Q; Chen H
Chin Med J (Engl); 2001 Apr; 114(4):339-43. PubMed ID: 11780449
[No Abstract] [Full Text] [Related]
12. Therapeutic implications of antibacterial resistance in community-acquired respiratory tract infections in children.
Cunha BA
Infection; 2004 Apr; 32(2):98-108. PubMed ID: 15057574
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration.
Chow AW; Hall CB; Klein JO; Kammer RB; Meyer RD; Remington JS
Clin Infect Dis; 1992 Nov; 15 Suppl 1(Suppl 1):S62-88. PubMed ID: 1477253
[TBL] [Abstract][Full Text] [Related]
14. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010.
Wang H; Chen M; Xu Y; Sun H; Yang Q; Hu Y; Cao B; Chu Y; Liu Y; Zhang R; Yu Y; Sun Z; Zhuo C; Ni Y; Hu B; Tan TY; Hsueh PR; Wang JH; Ko WC; Chen YH; Wahjono H
Int J Antimicrob Agents; 2011 Nov; 38(5):376-83. PubMed ID: 21880469
[TBL] [Abstract][Full Text] [Related]
16. An approach to pediatric upper respiratory infections.
Middleton DB
Am Fam Physician; 1991 Nov; 44(5 Suppl):33S-40S, 46S-47S. PubMed ID: 1950981
[TBL] [Abstract][Full Text] [Related]
17. Treatment of upper and lower respiratory tract infections: clinical trials with cefprozil.
Aronovitz G
Pediatr Infect Dis J; 1998 Aug; 17(8 Suppl):S83-8. PubMed ID: 9727656
[TBL] [Abstract][Full Text] [Related]
18. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin.
Felmingham D
J Infect; 2002 Feb; 44 Suppl A():3-10. PubMed ID: 12150493
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
[TBL] [Abstract][Full Text] [Related]
20. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods.
Gonzales R; Bartlett JG; Besser RE; Cooper RJ; Hickner JM; Hoffman JR; Sande MA
Ann Emerg Med; 2001 Jun; 37(6):690-7. PubMed ID: 11385342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
